Zuellig Pharma LTD

Zuellig Pharma LTD, a Thailand-based healthcare services provider and Asia's leading supplier of medical and laboratory solutions, has established itself as an experienced federal contractor serving U.S. defense and health agencies since 2014. The company specializes in providing critical medical supplies, laboratory reagents, diagnostic test kits, and specialized equipment maintenance services to support U.S. government operations, particularly those focused on infectious disease research and medical readiness in the Asia-Pacific region. Zuellig Pharma LTD has been awarded over 30 federal contracts as a prime contractor, with a registration in the System for Award Management (SAM.gov) that remains valid through October 15, 2026.

Zuellig Pharma LTD's federal contract portfolio demonstrates substantial expertise in laboratory support services and medical procurement. The company has provided an extensive range of goods and services including laboratory reagents, RNA and DNA extraction kits, antimicrobial susceptibility testing supplies, flow cytometer maintenance services, preventive maintenance for specialized laboratory equipment, vaccines, and consumable medical products such as vacutainers and test kits. Primary funding agencies include the Defense Health Agency, U.S. Army Medical Command (MEDCOM), Chief of Naval Operations, Department of State, Office of the Secretary of Defense, Centers for Disease Control and Prevention, and the Bureau of East Asian and Pacific Affairs. The majority of Zuellig Pharma LTD's contracts have been awarded without set-aside designations, indicating awards made under full and open competition. Contract values for individual awards have ranged from approximately $5,700 to $128,000, with performance periods typically extending through fiscal year completion dates. Notable contract work includes supporting the Armed Forces Research Institute of Medical Sciences (AFRIMS) in Bangkok, Thailand, with multiple maintenance contracts for sophisticated laboratory equipment, providing medical supplies for U.S. Embassy Bangkok operations, and delivering specialized research reagents to support various Department of Defense infectious disease research initiatives.

Zuellig Pharma LTD currently holds two significant Blanket Purchase Agreements (BPAs) as prime contractor vehicles. The first is a single-award BPA established with the Defense Health Agency on September 6, 2024, valued at $1,216,000 with an ultimate completion date of September 5, 2029, providing for the supply of laboratory reagents and medical supplies including consumable medical products and equipment maintenance and repair services for DHA facilities in Thailand. The second IDV is a single-award BPA awarded by the U.S. Army Medical Command on May 1, 2021, with a ceiling value of $565,776.90 and performance period extending through April 30, 2026, established for the acquisition of laboratory equipment maintenance services supporting AFRIMS facilities in Bangkok, including maintenance for BD LSRFortessa flow cytometers, BD Accuri flow cytometers, and additional specialized laboratory equipment such as QIAsymphony SP, QIAgility, QIAcube, Rotor-Gene Q, QIAxcel, and EZ-1 Advanced XL instruments. Both BPAs are structured as firm fixed-price contracts without set-aside designations, enabling Zuellig Pharma LTD to efficiently deliver mission-critical laboratory and medical support services to U.S. government agencies operating in Thailand.